Your browser doesn't support javascript.
loading
MiR-1207-5p targets PYCR1 to inhibit the progression of prostate cancer.
Xu, Haixia; He, Yan; Lin, Lin; Li, Meixiang; Zhou, Zeqiang; Yang, Yi.
Afiliação
  • Xu H; Department of Oncology, The First Affiliated Hospital of Shenzhen University, Shenzhen, 518000, Guangdong, China.
  • He Y; Department of Oncology, The First Affiliated Hospital of Shenzhen University, Shenzhen, 518000, Guangdong, China.
  • Lin L; Department of Oncology, The First Affiliated Hospital of Shenzhen University, Shenzhen, 518000, Guangdong, China.
  • Li M; Department of Oncology, The First Affiliated Hospital of Shenzhen University, Shenzhen, 518000, Guangdong, China.
  • Zhou Z; Department of Oncology, The First Affiliated Hospital of Shenzhen University, Shenzhen, 518000, Guangdong, China.
  • Yang Y; Department of Urology, the First Affiliated Hospital of Shenzhen University, Shenzhen, 518000, Guangdong, China. Electronic address: yangyi9335@163.com.
Biochem Biophys Res Commun ; 575: 56-64, 2021 10 20.
Article em En | MEDLINE | ID: mdl-34461437

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Pirrolina Carboxilato Redutases / MicroRNAs Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Pirrolina Carboxilato Redutases / MicroRNAs Idioma: En Ano de publicação: 2021 Tipo de documento: Article